- Home
- BTAI vs LTRN Comparison
BTAI vs LTRN Comparison
Compare BTAI & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTAI | LTRN |
|---|---|---|
| Founded | 2017 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.6M | 31.5M |
| IPO Year | 2018 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BTAI | LTRN |
|---|---|---|
| Price | $1.47 | $2.26 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $23.25 | ★ $25.00 |
| AVG Volume (30 Days) | ★ 1.2M | 48.0K |
| Earning Date | 05-11-2026 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $261.81 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.17 | $2.03 |
| 52 Week High | $8.08 | $5.74 |
Technical Indicators
Market Signals| Indicator | BTAI | LTRN |
|---|---|---|
| Relative Strength Index (RSI) | 41.75 | 32.45 |
| Support Level | $1.44 | N/A |
| Resistance Level | $2.22 | $3.65 |
| Average True Range (ATR) | 0.14 | 0.17 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 2.63 | 23.17 |
Price Performance
Historical ComparisonAbout BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.